BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32146705)

  • 1. Risk of Serious Ventricular Arrhythmia in Users of Gastrointestinal Medications: A Retrospective Cohort Study in China.
    Zhang Y; Shu M; Liang W; Jiang K; Zhang D; Qiu H; Wu K
    Adv Ther; 2020 Apr; 37(4):1564-1578. PubMed ID: 32146705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study.
    Johannes CB; Varas-Lorenzo C; McQuay LJ; Midkiff KD; Fife D
    Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):881-8. PubMed ID: 20652862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study.
    Arana A; Johannes CB; McQuay LJ; Varas-Lorenzo C; Fife D; Rothman KJ
    Drug Saf; 2015 Dec; 38(12):1187-99. PubMed ID: 26350642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of domperidone induced severe ventricular arrhythmia.
    Song BG; Lee YC; Min YW; Kim K; Lee H; Son HJ; Rhee PL
    Sci Rep; 2020 Jul; 10(1):12158. PubMed ID: 32699312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case-crossover study.
    Chen HL; Hsiao FY
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):841-8. PubMed ID: 26098410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between domperidone and ventricular arrhythmia in the postpartum period.
    Smolina K; Mintzes B; Hanley GE; Oberlander TF; Morgan SG
    Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1210-1214. PubMed ID: 27296864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: Case/non-case analysis in the national pharmacovigilance database].
    Rochoy M; Auffret M; Béné J; Gautier S;
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):1-8. PubMed ID: 27988172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Domperidone is Commonly Prescribed With QT-Interacting Drugs: Review of a Community-based Practice and a Postmarketing Adverse Drug Event Reporting Database.
    Ehrenpreis ED; Roginsky G; Alexoff A; Smith DG
    J Clin Gastroenterol; 2017 Jan; 51(1):56-62. PubMed ID: 27182647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metoclopramide, domperidone: sudden cardiac death, ventricular arrhythmia.
    Prescrire Int; 2016 Oct; 25(175):238-240. PubMed ID: 30645828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone and the Risk of Ventricular Arrhythmia, Cardiac Arrest, and Death Among Patients Receiving Lansoprazole.
    Bai AD; Wilkinson A; Almufleh A; Rai M; Razak F; Verma AA; Srivastava S
    JAMA Netw Open; 2023 Oct; 6(10):e2339893. PubMed ID: 37883084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domperidone and the risks of sudden cardiac death and ventricular arrhythmia: A systematic review and meta-analysis of observational studies.
    Ou LB; Moriello C; Douros A; Filion KB
    Br J Clin Pharmacol; 2021 Oct; 87(10):3649-3658. PubMed ID: 33439512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Domperidone and long QT syndrome.
    Rossi M; Giorgi G
    Curr Drug Saf; 2010 Jul; 5(3):257-62. PubMed ID: 20394569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Chronic Domperidone Use on QT Interval: A Large Single Center Study.
    Field J; Wasilewski M; Bhuta R; Malik Z; Cooper J; Parkman HP; Schey R
    J Clin Gastroenterol; 2019 Oct; 53(9):648-652. PubMed ID: 30720577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiac adverse effects of domperidone in adult patients: a systematic review].
    Marzi M; Weitz D; Avila A; Molina G; Caraballo L; Piskulic L
    Rev Med Chil; 2015 Jan; 143(1):14-21. PubMed ID: 25860264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Domperidone safety: a mini-review of the science of QT prolongation and clinical implications of recent global regulatory recommendations.
    Buffery PJ; Strother RM
    N Z Med J; 2015 Jun; 128(1416):66-74. PubMed ID: 26117678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey of the use of domperidone and the association with QTc prolongation in general practice.
    Ioannou A; Jain A; Kassianos G; Missouris C
    Postgrad Med J; 2016 Jul; 92(1089):390-2. PubMed ID: 26802127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands.
    van Noord C; Dieleman JP; van Herpen G; Verhamme K; Sturkenboom MC
    Drug Saf; 2010 Nov; 33(11):1003-14. PubMed ID: 20925438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domperidone and Risk of Ventricular Arrhythmia and Cardiac Death: A Systematic Review and Meta-analysis.
    Leelakanok N; Holcombe A; Schweizer ML
    Clin Drug Investig; 2016 Feb; 36(2):97-107. PubMed ID: 26649742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Domperidone for Hypotension in Parkinson's Disease: A Systematic Review.
    Bacchi S; Chim I; Kramer P; Postuma RB
    J Parkinsons Dis; 2017; 7(4):603-617. PubMed ID: 29103053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proarrhythmic effects of domperidone in infants: a systematic review].
    Caraballo L; Molina G; Weitz D; Piskulic L; Avila A; Marzi M
    Farm Hosp; 2014 Sep; 38(5):438-44. PubMed ID: 25344138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.